<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Why David Shedlarz Is Leaving Pfizer Now</title>
	<atom:link href="http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 19:35:41 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Paul</title>
		<link>http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/#comment-29160</link>
		<dc:creator>Paul</dc:creator>
		<pubDate>Wed, 28 Nov 2007 15:55:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/#comment-29160</guid>
		<description>Hi Ed,

What do you think is the best outcome relationship for Pfizer should it acquire Biogen?

Paul</description>
		<content:encoded><![CDATA[<p>Hi Ed,</p>
<p>What do you think is the best outcome relationship for Pfizer should it acquire Biogen?</p>
<p>Paul</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ed Silverman</title>
		<link>http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/#comment-23980</link>
		<dc:creator>Ed Silverman</dc:creator>
		<pubDate>Wed, 31 Oct 2007 12:18:35 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/#comment-23980</guid>
		<description>Dear Insider No. 2,

This wasn't just analysis, but sourced information. As I indicated in my first post when Shedlarz announced his retirement, he did, in fact, decide to leave but was lured back by being made vice chair. And he held a very prominent role in the first few months following his decision to remain. My info is that he was willing to stay beyond 2007, but the events of the past few months, as I indicated in this post, contributed to his change of mind and heart. If you have further info you would like to share, please do. In any event, thanks for writing in.

Regards

ed at Pharmalot</description>
		<content:encoded><![CDATA[<p>Dear Insider No. 2,</p>
<p>This wasn&#8217;t just analysis, but sourced information. As I indicated in my first post when Shedlarz announced his retirement, he did, in fact, decide to leave but was lured back by being made vice chair. And he held a very prominent role in the first few months following his decision to remain. My info is that he was willing to stay beyond 2007, but the events of the past few months, as I indicated in this post, contributed to his change of mind and heart. If you have further info you would like to share, please do. In any event, thanks for writing in.</p>
<p>Regards</p>
<p>ed at Pharmalot</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Insider</title>
		<link>http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/#comment-23977</link>
		<dc:creator>Insider</dc:creator>
		<pubDate>Wed, 31 Oct 2007 12:11:46 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/#comment-23977</guid>
		<description>Good analysis, but wrong.  Inside it was common knowledge that Shedlarz was going to leave by the end of the year.  He's wanted to leave ever since he was overlooked for the #1 position.  The only reason he stayed was the board gave him a sweet deal to stay thru 2007 to insure Wall Street didn't get too spooked with a fast foot lawyer in the #1 spot.</description>
		<content:encoded><![CDATA[<p>Good analysis, but wrong.  Inside it was common knowledge that Shedlarz was going to leave by the end of the year.  He&#8217;s wanted to leave ever since he was overlooked for the #1 position.  The only reason he stayed was the board gave him a sweet deal to stay thru 2007 to insure Wall Street didn&#8217;t get too spooked with a fast foot lawyer in the #1 spot.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Insider</title>
		<link>http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/#comment-23893</link>
		<dc:creator>Insider</dc:creator>
		<pubDate>Tue, 30 Oct 2007 16:08:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/10/why-david-shedlarz-is-leaving-pfizer-now/#comment-23893</guid>
		<description>Excellent speculation and analysis Ed.

J</description>
		<content:encoded><![CDATA[<p>Excellent speculation and analysis Ed.</p>
<p>J</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.150 seconds -->

